CEA Industries Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VAPE research report →
Price Chart
About the company
CEA Industries is an enterprise keenly focused on expansion, with a strategic objective to cultivate prominent, market-leading businesses within various regulated consumer sectors. The company's current activities encompass advanced controlled environment agriculture, primarily managed through its subsidiary Surna Cultivation Technologies, and involvement in Canada's nicotine vaping market. Within the vape sector, CEA Industries specifically seeks out and partners with highly scalable, profitable operators, with Fat Panda serving as a prime illustration of their target clientele.
- CEO
- Anthony McDonald
- IPO
- 2021
- Employees
- 6
- HQ
- Louisville, CO, US
Get TickerSpark's AI analysis on VAPE
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.95M
- P/E
- -1.92
- Fwd P/E
- 3.76
- PEG
- 0.01
- P/S
- 0.00
- P/B
- 1.46
- EV/EBITDA
- -0.00
- Div Yield
- 0.00%
- Gross Margin
- 29.30%
- Op Margin
- 1252.04%
- Net Margin
- 3960.44%
- ROE
- 233.71%
- ROIC
- 19641.13%
Latest fiscal year · YoY change
- Revenue
- $2.80M-59.4%
- Gross Profit
- $-219,624-140.5%
- Op Income
- $-3,172,084
- Net Income
- $-3,145,943-8.1%
- EPS
- $-4.22+2.5%
- OCF Growth
- +50.1%
- FCF Growth
- +50.1%
- 52W High
- $82.88
- 52W Low
- $6.79
- 50D MA
- $16.53
- 200D MA
- $16.08
- Beta
- 0.78
- RSI (14)
- 48
- Avg Volume
- 469.44K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
CEA Industries reported sharply lower Q2 revenue and bookings as cannabis/control-ag sector spending slowed, but cut costs aggressively and launched a strategic alternatives review.· August 14, 2023
- Q2 revenue fell to $1.1 million from $3 million a year ago as industry capex weakness hurt bookings and backlog.
- Gross profit was about $79,000, or 7.4% of revenue, versus $300,000 and 10.2% last year.
- Operating expenses dropped 62% year over year to about $800,000, and were down 38% from Q1 2023.
- Net loss improved to about $700,000, or $0.09 per share, versus $1.8 million, or $0.23 per share, a year ago.
- The company started a strategic alternatives review, including a possible sale, merger, or other transaction, while staying debt free with $14.2 million in cash.
Q2 revenue was $1.1 million, down from $3 million in the year-ago period. Gross profit was approximately $79,000, or 7.4% of revenue, compared with $300,000, or 10.2%, last year. Operating expenses decreased 62% to about $800,000 from $2.1 million a year ago, and net loss improved to about $700,000, or negative $0.09 per share, versus a net loss of $1.8 million, or negative $0.23 per share. Net bookings were approximately $200,000 versus $1.5 million a year ago, and quarter-end backlog was $1.1 million versus $9.7 million. Cash and cash equivalents were $14.2 million at June 30, 2023, compared with $18.6 million at December 31, 2022; the company remained debt free. No explicit revenue or EPS guidance was provided, but management said it expects to keep running a lean operation, seek additional cost savings, and pursue new contract wins in cannabis and traditional agriculture.
Tony McDonald framed the quarter as another period of pressure from pricing, inflation, and reduced capital spending in cannabis and controlled environment agriculture, which has delayed or eliminated projects and hurt bookings and revenue. His emphasis was on discipline: more than 60% lower operating expenses versus the prior year, continued capital allocation restraint, and a push to preserve service quality while reducing costs further. He also highlighted the strategic alternatives review as a key value-protection step, saying the board is considering a sale, merger, or other transaction and will not comment further until appropriate.
Ian Patel focused on the hard numbers behind the downturn and the cost response. He noted revenue of $1.1 million, gross margin of 7.4%, net bookings of about $200,000, and backlog of $1.1 million, all reflecting fewer capital projects in the market. On expenses, he said OpEx fell 62% year over year to about $800,000 and 38% sequentially from Q1, and he highlighted $14.2 million in cash at quarter-end, a $900,000 decline in working capital, and a debt-free balance sheet.
On strategic alternatives, management said updates will be provided only as the board deems appropriate, and that the process is being run broadly to maximize shareholder value. When asked what they want in a partner or acquirer, they said they are “casting a wide net” and will consider both inside and outside the cannabis and CEA industries. They also acknowledged a slowdown in contract opportunities and said sales and marketing spending was reduced accordingly, while continuing to evaluate new business and serve existing customers.
The main bull case is that management has already taken major actions to lower the cost base, with OpEx down 62% year over year and 38% sequentially, which may help preserve cash through a weak demand period. The company also still has $14.2 million in cash, no debt, and is actively pursuing a strategic alternatives process that could unlock value.
The bear case is that demand remains weak, with revenue, bookings, and backlog all sharply below year-ago levels because customers are delaying or cutting capex. Management also said the slowdown in contract opportunities has reduced sales and marketing efforts, and there is no concrete turnaround guidance or timing for the strategic review.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 73.2%
- Shares Outstanding
- 841.35K
- Float Shares
- 615.45K
Buy/sell ratio 6.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 5, 25 | Tarallo Matthew | other | 1,529 |
| Aug 5, 25 | Tarallo Matthew | sell | 1,529 |
| Jul 27, 25 | ETTEN NICHOLAS J. | other | 119,669 |
| Jul 27, 25 | Tarallo Matthew | other | 5,790 |
| Jul 27, 25 | Mariathasan Marion | other | 40,533 |
| Jul 27, 25 | Shipley James Randall | other | 96,507 |
| Jul 27, 25 | McDonald Anthony K | other | 223,125 |
| Jan 12, 16 | Scialdone Mark | sell | 250,000 |
| Dec 10, 15 | Tracey Kyle J | other | 30,000,000 |
| Oct 22, 15 | Beaulieu Benjamin | other | 600,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VAPE coverage
Recent articles, reports, and earnings notes.
No research on VAPE yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VAPE report →American Battery Technology, Quantum Computing, CEA Industries And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com · Sep 22
CEA Industries Closes $500 Million Private Placement to Advance Its BNB Treasury Strategy; Common Stock Ticker to Become “BNC”
globenewswire.com · Aug 5
CEA Industries Inc. Announces Ticker Symbol Change to “BNC” for Common Stock and “BNCWW” for Warrants
globenewswire.com · Aug 5
Time to Buy, Hold, or Sell CEA Industries (VAPE) Stock?
zacks.com · Jul 29
CEA Industries Launches BNB Treasury
youtube.com · Jul 29
Up 6x, Is VAPE Stock The Next Big Crypto Treasury Play?
forbes.com · Jul 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.